Published in Eur J Pharm Biopharm on July 01, 2001
Steps to translate preconditioning from basic research to the clinic. Transl Stroke Res (2012) 0.88
Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells. Oncotarget (2014) 0.87
Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin. Int J Nanomedicine (2015) 0.79
The effects of selected Australian snake venoms on tumour-associated microvascular endothelial cells (TAMECs) in vitro. J Venom Res (2013) 0.75
A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res (1999) 3.19
Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Control Release (2000) 1.59
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm (1998) 1.54
Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release (2005) 1.38
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm (2000) 1.33
In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm (2004) 1.26
Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol Appl Pharmacol (2006) 1.19
Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm Res (1996) 1.16
In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks. J Biomed Mater Res (1996) 1.07
Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharm Res (2001) 1.07
Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation. J Control Release (1999) 1.04
Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. Eur J Pharm Biopharm (1998) 1.01
Intestinal absorption of the octapeptide SMS 201-995 visualized by fluorescence derivatization. Gastroenterology (1991) 1.01
Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination. J Control Release (2005) 1.01
Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles. Pharm Dev Technol (2000) 1.00
Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres. J Microencapsul (1999) 0.98
Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm (2006) 0.98
Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion? Eur J Pharm Biopharm (2001) 0.97
Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. J Control Release (1998) 0.96
In vivo biocompatibility and biodegradation of poly(ethylene carbonate). J Control Release (2003) 0.93
Gamma irradiation for terminal sterilization of 17beta-estradiol loaded poly-(D,L-lactide-co-glycolide) microparticles. J Control Release (1999) 0.92
Chemo-embolization of experimental liver metastases. Part I: distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy. Eur J Pharm Biopharm (1998) 0.91
Particulate nanomedicines. Adv Drug Deliv Rev (2006) 0.91
Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J Control Release (1998) 0.91
Development of a human nasal epithelial cell culture model and its suitability for transport and metabolism studies under in vitro conditions. Pharm Res (1995) 0.90
Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm Res (2001) 0.90
Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J Microencapsul (2000) 0.89
Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques. J Microencapsul (2005) 0.89
Therapeutic angiogenesis. Arch Surg (1993) 0.89
Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Ther (2002) 0.89
Enteral absorption of octreotide. Br J Pharmacol (1992) 0.89
The absorption site of cyclosporin in the human gastrointestinal tract. Br J Clin Pharmacol (1992) 0.88
The degradation, swelling and erosion properties of biodegradable implants prepared by extrusion or compression moulding of poly(lactide-co-glycolide) and ABA triblock copolymers. Biomaterials (2000) 0.87
Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. J Control Release (1999) 0.87
Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(d,l-lactide-co-glycolide): effects of polymer structure on cytotoxicity. Biomaterials (2006) 0.87
Enhancement of the oral absorption of cyclosporin in man. Br J Clin Pharmacol (1992) 0.87
Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid). J Control Release (2001) 0.86
Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine (1992) 0.85
Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models. J Control Release (1998) 0.84
In-vitro cell culture models of the nasal epithelium: a comparative histochemical investigation of their suitability for drug transport studies. Pharm Res (1996) 0.84
Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization. J Control Release (2004) 0.84
Pharmacokinetics of the transdermal reservoir membrane system delivering beta-estradiol: in vitro/in vivo-correlation. Pharm Res (1998) 0.83
Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. J Control Release (1998) 0.83
Staurosporine-induced apoptosis in cultured chick embryonic neurons is reduced by polyethylenimine of low molecular weight used as a coating substrate. Neurosci Res (2000) 0.83
Cell type specificity of the human endoglin promoter. Gene (1999) 0.82
Bovine serum albumin loaded poly(lactide-co-glycolide) microspheres: the influence of polymer purity on particle characteristics. J Microencapsul (1998) 0.82
Modified polyethylenimines as non viral gene delivery systems for aerosol therapy: effects of nebulization on cellular uptake and transfection efficiency. J Control Release (2004) 0.81
Poly(ethylene carbonate): a thermoelastic and biodegradable biomaterial for drug eluting stent coatings? J Control Release (2006) 0.81
Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics. J Control Release (1999) 0.81
Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA. Pharm Res (2003) 0.81
Prevention of peritoneal adhesions in the rat with sustained intraperitoneal dexamethasone delivered by a novel therapeutic system. Ann Chir Gynaecol (1987) 0.80
Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): evidence for an active transport component? Pharm Res (1994) 0.79
Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: evaluation of different techniques for the encapsulation of pamidronate di-sodium salt. J Microencapsul (2003) 0.79
Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymers. J Drug Target (2000) 0.79
On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles. J Control Release (2007) 0.78
The human keratinocyte cell line HaCaT: an in vitro cell culture model for keratinocyte testosterone metabolism. Pharm Res (1999) 0.78
Biodegradable semi-crystalline comb polyesters influence the microsphere production by means of a supercritical fluid extraction technique (ASES). J Control Release (2000) 0.78
Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine (1999) 0.78
Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations. Br J Pharmacol (1996) 0.78
The development of IL-2 conjugated liposomes for therapeutic purposes. Biochim Biophys Acta (1998) 0.78
Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres. J Control Release (2000) 0.77
Cationized human serum albumin as a non-viral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efficiency. Int J Pharm (2001) 0.77
Branched biodegradable polyesters for parenteral drug delivery systems. J Control Release (2000) 0.77
Transport of peptidomimetic renin inhibitors across monolayers of a human intestinal cell line (Caco-2): evidence for self-enhancement of paracellular transport route. Pharm Res (1995) 0.77
Effect of intravenous infusions of thiamine on the disposition kinetics of thiamine and its pyrophosphate. J Clin Pharm Ther (2003) 0.77
Evaluation of absorption enhancement for a potent cyclopeptidic alpha(nu)beta(3)-antagonist in a human intestinal cell line (Caco-2). Eur J Pharm Sci (2000) 0.76
Transport of peptidomimetic thrombin inhibitors with a 3-amidino-phenylalanine structure: permeability and efflux mechanism in monolayers of a human intestinal cell line (Caco-2). Pharm Res (2001) 0.75
Pharmacokinetics and pharmacodynamics of a new transdermal delivery system for bopindolol. Br J Clin Pharmacol (1991) 0.75
[Away with the needle. Noninvasive administration routes for insulin: improved quality of life for diabetics?]. Pharm Unserer Zeit (2001) 0.75
Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part II: Implants allowing controlled drug release--a feasibility study using bisphosphonates. J Microencapsul (2004) 0.75
MRI contrast enhancement potential of different superparamagnetic iron oxide nanoparticle (SPION) formulations. J Control Release (2010) 0.75
Rate control in transdermal beta-estradiol reservoir membrane systems: the role of membrane and adhesive layer. Pharm Res (1998) 0.75
Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2). Pharm Res (1996) 0.75
Transepithelial transport properties of peptidomimetic thrombin inhibitors in monolayers of a human intestinal cell line (Caco-2) and their correlation to in vivo data. Pharm Res (1995) 0.75
Dielectric and thermodynamic properties of biodegradable poly(D,L-lactide-co-glycolide) and the effect on the micro-encapsulation and release of captopril. J Microencapsul (1997) 0.75
Effects of peptide structure on transport properties of seven thyrotropin releasing hormone (TRH) analogues in a human intestinal cell line (Caco-2). Pharm Res (1997) 0.75
Growth effects of alpha-interferon but not of bombesin or angiotensin II are mediated by activation of STAT proteins. Eur J Clin Invest (1998) 0.75
Biotransformation of estradiol in the human keratinocyte cell line HaCaT: metabolism kinetics and the inhibitory effect of ethanol. Pharm Res (1998) 0.75
Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data. Pharm Res (1999) 0.75